Preeclampsia Risk and IVF Cycles Guidance

The FDA has released guidance addressing the association between in vitro fertilization (IVF) cycles and an increased risk of preeclampsia. The document outlines current understanding of this risk, potential contributing factors, and recommendations for monitoring and management during pregnancy.

Healthcare providers should familiarize themselves with this guidance to counsel patients undergoing or considering IVF about potential pregnancy complications. Patients should discuss these risks with their fertility specialists and obstetricians to ensure appropriate prenatal care and monitoring. While this is guidance and not a binding rule, adherence is recommended to ensure patient safety and informed consent.